Ortho Sales Partners forming orthopedics and spine divisions, announces two executive additions: 4 things to know

Ortho Sales Partners, a company providing commercialization services for the orthopedic industry, is forming distinct orthopedics and spine divisions. The company hired Jeff Chandler and Dan Darges to lead the orthopedics division.

Advertisement

Here are four things to know.

 

1. Mr. Chandler has extensive experience commercializing total joint reconstruction, trauma and sports medicine products. Mr. Chandler was the founder, CEO and president of venture capital-backed medical device firm Aquarius Medical, which he led for six years.

 

2. Mr. Darges began his career as an orthopedic reconstruction and trauma representative at Smith & Nephew. In 2007, Mr. Darges founded Bio-Surg Solutions, a distributorship for Wright Medical. In 2012, he became a senior director of sales for Wright Medical’s foot and ankle and biologics products.

 

3. Ortho Sales Partners promoted Matt Stuttle to general manager of the spine division. In the past, Mr. Stuttle has held executive management positions at Kyphon Paradigm Spine, SpineWave and most recently Spineart.

 

4. As co-general managers, Mr. Chandler and Darges will report to Ortho Sales Partners CEO Kevin McGann.

 

More articles on devices:

 Implanet, L&K Biomed finalize partnership: 4 key points

Stryker prices $600M senior notes offering: 4 highlights

DePuy Synthes recognized for promoting female engineers: 5 takeaways

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new product launches and leadership appointments, here are seven key headlines from Stryker in the first quarter of 2026.…

  • Xtant Medical’s 2025 revenue reached $133.9 million, a 14% increase year over year, according to financial results posted March 31.…

Advertisement

Comments are closed.